Toru Sugiyama
0000-0002-2385-9040
1 paper found
Refreshing results…
Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial
Missing publications? Search for publications with a matching author name.